• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Pindrop Secures $100 Million Financing To Accelerate Fraud And Deepfake Detection Technologies

    7/17/24 9:00:00 AM ET
    $HTGC
    Investment Managers
    Finance
    Get the next $HTGC alert in real time by email

    This additional funding comes at an instrumental time for Pindrop as the company continues to innovate groundbreaking voice security and authentication solutions

    ATLANTA, July 17, 2024 /PRNewswire/ -- Pindrop, a global leader in voice authentication and security, today announced it has secured $100 million in debt financing from Hercules Capital, Inc. (NYSE:HTGC). This significant funding will enable Pindrop to further develop its cutting-edge audio, voice, and AI technologies, enhancing its offerings for customers in the banking, finance, contact center, insurance, utilities, healthcare, retail, and other industries.

    Pindrop (PRNewsfoto/Pindrop)

    Contact centers, which play a crucial role in these sectors, are becoming increasingly vulnerable as cyberattacks grow more sophisticated. As a result, contact center fraud has surged by 60% in the last two years, reaching the highest levels since 2019. By the end of this year, one in every 730 calls to a contact center is expected to be fraudulent. Posing an estimated $5 billion fraud risk to U.S. contact centers, voice authentication solutions are imperative in keeping a company secure.

    On a mission to shape the future of voice security and authentication against the rising threats mainly caused by generative AI, Pindrop's technologies help organizations to detect fraudsters and authenticate genuine customers at scale. To date, Pindrop has analyzed 5.3 billion calls, prevented $2 billion in fraud losses, and detected 104 million spoof calls. Dedicated to leveraging good AI to combat bad AI, Pindrop is making significant strides in the fight against deepfakes.

    "We're pleased to secure this financing with Hercules Capital at such a pivotal moment for Pindrop," said Pindrop Founder & CEO, Vijay Balasubramaniyan. "This funding will fuel our ongoing growth and innovation in voice and AI technologies. As cyber threats continue to evolve, our mission to stay ahead of fraudsters and protect our customers is more critical than ever. We're excited about the future as we remain committed to driving advancements that safeguard major institutions and deliver unparalleled security in the digital age."

    John Chambers, Pindrop Investor and Board Member, Founder & CEO of JC2 Ventures, and former Executive Chairman and CEO of Cisco, added, "In December 2023, I predicted that deepfakes would be the #1 issue for companies and countries alike in 2024, which has been extremely accurate. In my career, I have had the opportunity to help position companies to lead in these big market transitions, and I can say with confidence that Pindrop is uniquely positioned to do just that with their revolutionary voice security and authentication technology. What's more, they developed their product in a matter of months, brought it to market, and secured their first five or six references the very next quarter. The entire VC group on their Board of Directors immediately invested in this effort and, under Vijay's leadership, Pindrop will achieve the fastest run rate to $5 million in an entirely new product area by an existing company, compared to any other company I have seen. This new investment from Hercules Capital comes at a pivotal time for Pindrop, enabling them to further develop their cutting-edge audio, voice, and AI technologies and enhance their offerings for customers in the banking, finance, contact center, and insurance industries."

    Earlier this year, Pindrop notably identified the Text-to-Speech (TTS) engine used in the President Biden robocall attack urging New Hampshire voters not to vote during the Democratic primaries. As AI's impact on this year's election drew more attention from legislators and regulators. Pindrop has been honored to have its CEO participate in the US Senate Forum On AI, the Attorneys General Spring Symposium, and the House Financial Services Committee's Bipartisan AI Working Group Roundtable.

    This announcement follows several key milestones for Pindrop:

    • The release of Pindrop® Pulse, an innovative audio deepfake detection solution offering real-time identification, monitoring, and analysis of audio deepfakes with advanced liveness detection technology.
    • The launch of its 2024 Voice Intelligence and Security Report, which provides an in-depth analysis of the current fraud and security landscape while highlighting future trends and new prevention techniques.
    • The debut of the Pulse Deepfake Warranty, a pioneering warranty that reimburses eligible customers if the Pindrop Product Suite fails to detect a deepfake or synthetic voice fraud, offering peace of mind and maintaining cutting-edge defense against evolving cyber threats.

    "Hercules is incredibly excited to partner with Pindrop as they continue working to transform the AI and voice authentication landscape," said John Eggbeer, Managing Director, Hercules Capital, Inc. (NYSE:HTGC). "We're proud to support their mission of safeguarding major institutions from rising cyberattack threats. This financing will help accelerate their growth and innovation, enabling them to expand their reach and enhance their capabilities in providing robust security solutions."

    Pindrop continues to lead the way in voice authentication and security, ensuring robust protection against fraud and enhancing the safety of digital interactions for its customers. For more information, please visit www.pindrop.com.

    About Pindrop:

    Pindrop's solutions are leading the way to the future of voice by establishing the standard for identity, security, and trust for every voice interaction. Pindrop's solutions protect some of the world's biggest banks, insurers, and retailers using patented technology that extracts intelligence from every call and voice encountered. Pindrop solutions help detect fraudsters and authenticate genuine customers, reducing fraud and operational costs while improving customer experience and protecting brand reputation. Pindrop, a privately held company headquartered in Atlanta, GA, was founded in 2011 by Dr. Vijay Balasubramaniyan, Dr. Paul Judge, and Dr. Mustaque Ahamad and is venture-backed by Andreessen Horowitz, Citi Ventures, Felicis Ventures, CapitalG, GV, IVP, and Vitruvian Partners. For more information, please visit pindrop.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pindrop-secures-100-million-financing-to-accelerate-fraud-and-deepfake-detection-technologies-302198850.html

    SOURCE Pindrop

    Get the next $HTGC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HTGC

    DatePrice TargetRatingAnalyst
    12/12/2024$19.50 → $21.50Mkt Perform → Outperform
    Keefe Bruyette
    1/16/2024$17.00 → $17.50Buy → Neutral
    Compass Point
    11/21/2023$17.00Neutral
    UBS
    8/30/2023$17.50Neutral → Buy
    Compass Point
    8/4/2023$13.50 → $17.00Underperform → Mkt Perform
    Keefe Bruyette
    4/6/2023$16.00Neutral → Overweight
    Piper Sandler
    3/13/2023$14.50 → $10.50Mkt Perform → Underperform
    Keefe Bruyette
    7/29/2022Outperform → Perform
    Oppenheimer
    More analyst ratings

    $HTGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer & CCO Botelho Kiersten Zaza covered exercise/tax liability with 770 shares, decreasing direct ownership by 1% to 65,881 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:48 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Operating Officer Follmann Christian covered exercise/tax liability with 829 shares, decreasing direct ownership by 0.69% to 119,423 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:28 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Financial Officer Meyer Seth H covered exercise/tax liability with 4,051 shares, decreasing direct ownership by 1% to 377,121 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:12 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

    CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

    9/3/25 5:17:09 PM ET
    $HTGC
    $SENS
    Investment Managers
    Finance
    Industrial Machinery/Components
    Industrials

    Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. ("KBRA") has affirmed Hercules' investment grade corporate and credit rating of BBB+. KBRA issued a statement announcing the affirmation of the rating and stable outlook, as well as its underlying analysis. The affirmed BBB+ rating reflects the Company's diversified investment portfolio with a focus on senior secured first lien venture debt investments in the technology

    8/19/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile

    CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with Hercules Capital, Inc. (NYSE:HTGC), due in 2030, which provides $110.0 million in committed capital at closing and an additional $40.0 million in two $20.0 million tranches available upon achievement of certain milestones, to be drawn at the Company's discretion;An exc

    8/8/25 7:45:00 AM ET
    $HRTX
    $HTGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    $HTGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Follmann Christian sold $7,043 worth of shares (395 units at $17.83) and bought $7,043 worth of shares (395 units at $17.83), increasing direct ownership by 0.22% to 121,212 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    6/5/25 6:38:34 PM ET
    $HTGC
    Investment Managers
    Finance

    Director Theodosopoulos Nikos bought $104,923 worth of shares (5,999 units at $17.49), increasing direct ownership by 101% to 11,960 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    5/9/25 4:22:23 PM ET
    $HTGC
    Investment Managers
    Finance

    Director Loo Wade bought $104,923 worth of shares (5,999 units at $17.49), returned 5,645 shares to the company and was granted 5,645 shares, increasing direct ownership by 5% to 7,504 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    5/9/25 4:22:04 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hercules Capital upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Hercules Capital from Mkt Perform to Outperform and set a new price target of $21.50 from $19.50 previously

    12/12/24 8:09:58 AM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital downgraded by Compass Point with a new price target

    Compass Point downgraded Hercules Capital from Buy to Neutral and set a new price target of $17.50 from $17.00 previously

    1/16/24 8:29:29 AM ET
    $HTGC
    Investment Managers
    Finance

    UBS initiated coverage on Hercules Capital with a new price target

    UBS initiated coverage of Hercules Capital with a rating of Neutral and set a new price target of $17.00

    11/21/23 7:31:43 AM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    SEC Filings

    View All

    Hercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    7/31/25 4:30:57 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form 10-Q filed by Hercules Capital Inc.

    10-Q - Hercules Capital, Inc. (0001280784) (Filer)

    7/31/25 4:17:31 PM ET
    $HTGC
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Hercules Capital Inc.

    SCHEDULE 13G/A - Hercules Capital, Inc. (0001280784) (Subject)

    7/8/25 2:09:57 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Financials

    Live finance-specific insights

    View All

    Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

    CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

    9/3/25 5:17:09 PM ET
    $HTGC
    $SENS
    Investment Managers
    Finance
    Industrial Machinery/Components
    Industrials

    Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile

    CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with Hercules Capital, Inc. (NYSE:HTGC), due in 2030, which provides $110.0 million in committed capital at closing and an additional $40.0 million in two $20.0 million tranches available upon achievement of certain milestones, to be drawn at the Company's discretion;An exc

    8/8/25 7:45:00 AM ET
    $HRTX
    $HTGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    Hercules Capital Reports Second Quarter 2025 Financial Results

    Q2 2025 Total Gross Debt and Equity Commitments of $1.0 Billion Record Q2 2025 Total Gross Fundings of $709.1 Million Record 1H 2025 Total Gross Debt and Equity Commitments of $2.02 Billion Record 1H 2025 Total Gross Fundings of $1.25 Billion Record Q2 2025 Net Investment Income "NII" of $88.7 Million Q2 2025 NII of $0.50 per Share provides 125% Coverage of the Base Cash Distribution Closed Upsized Offering of $350.0 Million of 6.000% Unsecured Notes due 2030 Renewed and Increased Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 95.0% and Net Regulatory Leverage of 78.7%(1) Inclusive of the Adviser F

    7/31/25 4:07:00 PM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Leadership Updates

    Live Leadership Updates

    View All

    Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing

    Strategic growth financing accelerates expansion through acquisition and supports product innovation Snappt, the leading platform for applicant trust in multifamily housing, today announced it has acquired Trigo, a company known for its breakthrough technology in verifying rental payment history. Backed by a $50 million committed facility from Hercules Capital, Inc. (NYSE:HTGC), the acquisition expands Snappt's platform and strengthens its ability to help property managers make faster, more confident leasing decisions. Together, these milestones mark a major step toward building the industry's most complete and trusted solution embedded into the application and screening process. "This

    8/5/25 12:00:00 PM ET
    $HTGC
    Investment Managers
    Finance

    Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer

    SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. Mr. Olson has an extensive background in the venture capital and funds management industry. His addition to the team will enhance the firm's technical expertise, support the differentiated investment model, and strengthen the firm's ongoing foundation. As the firm's new Chief Financial Officer and Chief Operating Officer

    11/29/23 1:01:00 PM ET
    $HTGC
    $TPVG
    Investment Managers
    Finance
    Other Consumer Services
    Consumer Discretionary

    Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an independent member of its board of directors, effective September 21, 2023. Mr. Theodosopoulos is an experienced corporate executive and board director with more than 38 years in senior management roles in both the financial services and technology industries. Mr. Theodosopoulos will serve on the Company's Audit Committee. "Nikos' combined experienc

    9/25/23 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Subject)

    5/8/23 5:06:26 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Hercules Capital Inc. (Amendment)

    SC 13G/A - Hercules Capital, Inc. (0001280784) (Filed by)

    10/12/22 9:11:00 AM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Filed by)

    4/27/22 4:31:08 PM ET
    $HTGC
    Investment Managers
    Finance